Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1531 (R)-baclofenTarget: GABAB ReceptorsSummary: GABA receptor agonist
- B1454 RofecoxibTarget: COXSummary: COX-2 inhibitor
- B1001 Loxapine1 CitationTarget: 5-HT2 ReceptorsSummary: 5-HT receptor antagonist
- B1203 Iloperidone hydrochlorideSummary: D(2)/5-HT(2) receptor antagonistis
- B1553 Tripelennamine HClSummary: H1-receptor antagonist
- B1266 GlycopyrrolateSummary: Muscarinic competitive antagonist
- B1239 Parecoxib SodiumSummary: COX-2 inhibitor
- B1091 DeracoxibSummary: Selective COX-2 inhibitor
- B1626 LY404039Summary: MGlu2 and mGlu3 receptors agonist
- B1444 EtodolacSummary: COX-2 inhibitor